Mannkind Corp (MNKD) |
|
3.38 -0.24 (-6.63%)
|
03-05 08:57 |
|
Open: |
3.61 |
Pre. Close: |
3.62 |
|
High:
|
3.67 |
Low:
|
3.27 |
|
Volume:
|
7,981,936 |
Market Cap:
|
824M |
|
|
|
|
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.676 - 3.701 |
3.701 - 3.721 |
|
Low:
|
3.209 - 3.24 |
3.24 - 3.265 |
|
Close:
|
3.335 - 3.379 |
3.379 - 3.413 |
|
Technical analysis |
as of: 2021-03-05 8:13:39 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.97  One year: 7.30 |
| Support: |
Support1: 3.27 Support2: 2.72 |
| Resistance: |
Resistance1: 5.11 Resistance2: 6.25 |
| Pivot: |
5.08 |
| Moving Average: |
MA(5): 4.10 MA(20): 5.12
MA(100): 3.36  MA(250): 2.26 |
| MACD: |
MACD(12,26): -0.04 Signal(9): 0.29 |
| Stochastic oscillator: |
%K(14,3): 2.78 %D(3): 10.88 |
| RSI: |
RSI(14): 36.87 |
| 52-week: |
High: 6.25 Low: 0.80 Change(%): 152.2 |
| Average Vol(K): |
3-Month: 622706 10-Days: 1065369 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.MNKD has closed above bottom band by 1.2%. Bollinger Bands are 204.8% wider than normal. The large width of the bands suggest high volatility as compared to MNKD's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 04 Mar 2021
MannKind Corporation (MNKD) Plunges 6.63% on March 04 - Equities.com
Tue, 02 Mar 2021
MannKind Corporation: Bullish On High-Growth Inhaled Insulin Opportunity - Seeking Alpha
Mon, 01 Mar 2021
Can You Imagine How Elated MannKind's (NASDAQ:MNKD) Shareholders Feel About Its 350% Share Price Gain? - Yahoo Finance
Fri, 26 Feb 2021
MannKind Corporation (MNKD) Soars 1.78% on February 26 - Equities.com
Thu, 25 Feb 2021
MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results - Yahoo Finance
Fri, 19 Feb 2021
Insiders Seeing Green With MNKD At New 52-Week High - Nasdaq
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
236 |
| Shares Float (M) |
222 |
|
% Held by Insiders
|
4.86 |
|
% Held by Institutions
|
29.95 |
|
Shares Short (K)
|
17,190 |
|
Shares Short P. Month (K)
|
18,010 |
Stock Financials |
|
EPS
|
-0.209 |
|
EPS Est This Year
|
-0.910 |
|
EPS Est Next Year
|
-0.760 |
|
Book Value (p.s.)
|
-0.810 |
|
Profit Margin
|
-71.92 |
|
Operating Margin
|
-43.14 |
|
Return on Assets (ttm)
|
-17.7 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
5.2 |
|
Gross Profit (p.s.)
|
0.149 |
|
Sales Per Share
|
0.266 |
|
EBITDA (p.s.)
|
-0.107 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-33 |
|
Levered Free Cash Flow (M)
|
-18 |
Stock Valuations |
|
PE Ratio
|
-16.17 |
|
PEG Ratio
|
|
|
Price to Book value
|
-4.17 |
|
Price to Sales
|
12.71 |
|
Price to Cash Flow
|
-23.80 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
